Loading...
The time from date of randomization until the first occurrence of disease progression (according to mRECIST) or death due to any cause, whichever occurs first.
The proportion of patients with the best response of complete response (CR) or partial response (PR) according to mRECIST.
The proportion of patients with the best response of CR, PR, or stable disease (SD) according to mRECIST.
The time from date of randomization to death due to any cause.
Number of patients with AEs assessed by Common Terminology Criteria for Adverse Events v5.0.